X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (34) 34
male (22) 22
female (19) 19
electrocardiography (17) 17
aged (16) 16
middle aged (16) 16
cardiac & cardiovascular systems (15) 15
index medicus (14) 14
adult (12) 12
atrial fibrillation (11) 11
myocardial infarction - complications (8) 8
follow-up studies (7) 7
italy (7) 7
prognosis (7) 7
aged, 80 and over (6) 6
anti-arrhythmia agents - therapeutic use (6) 6
risk factors (6) 6
therapy (6) 6
adolescent (5) 5
analysis (5) 5
anticoagulants (5) 5
atrial fibrillation - therapy (5) 5
monitoring, physiologic (5) 5
arrhythmias, cardiac - diagnosis (4) 4
arrhythmias, cardiac - therapy (4) 4
atrial fibrillation - complications (4) 4
atrial fibrillation - physiopathology (4) 4
cardiology (4) 4
heart failure (4) 4
pacemaker (4) 4
practice guidelines as topic (4) 4
recurrence (4) 4
societies, medical (4) 4
surveys and questionnaires (4) 4
survival analysis (4) 4
algorithms (3) 3
atrial fibrillation - drug therapy (3) 3
cardiac pacing, artificial - standards (3) 3
cardiomyopathy (3) 3
cardiomyopathy, hypertrophic - physiopathology (3) 3
cardiovascular (3) 3
care and treatment (3) 3
efficacy (3) 3
electrocardiography, ambulatory (3) 3
esc guidelines (3) 3
incidence (3) 3
italy - epidemiology (3) 3
management (3) 3
medicine, general & internal (3) 3
pacemaker, artificial (3) 3
population (3) 3
practice patterns, physicians' - statistics & numerical data (3) 3
prospective studies (3) 3
research (3) 3
rhythm control (3) 3
studies (3) 3
sudden death (3) 3
treatment outcome (3) 3
angina pectoris, variant - diagnosis (2) 2
anticoagulants - therapeutic use (2) 2
anticoagulation (2) 2
arrhythmia (2) 2
arrhythmias (2) 2
arrhythmias, cardiac - drug therapy (2) 2
arrhythmias, cardiac - etiology (2) 2
atrial fibrillation - epidemiology (2) 2
atrial fibrillation - prevention & control (2) 2
bradyarrhythmias (2) 2
bradycardia (2) 2
bradycardia - therapy (2) 2
cardiac arrhythmia (2) 2
cardiac pacing, artificial - methods (2) 2
cardiomyopathy, hypertrophic - complications (2) 2
cardiomyopathy, hypertrophic - drug therapy (2) 2
catheter ablation (2) 2
closed-loop stimulation (2) 2
complications (2) 2
consensus (2) 2
death (2) 2
death, sudden, cardiac - etiology (2) 2
defibrillators (2) 2
defibrillators, implantable - trends (2) 2
device setting (2) 2
drug therapy (2) 2
electric countershock - instrumentation (2) 2
electric countershock - trends (2) 2
euro heart survey (2) 2
fibrinolytic agents - therapeutic use (2) 2
health care surveys (2) 2
heart diseases - mortality (2) 2
heart rate (2) 2
hemodynamics (2) 2
hospitalization (2) 2
hypertrophy (2) 2
implantable cardioverter defibrillator (2) 2
implantable cardioverter-defibrillator (2) 2
internal medicine - methods (2) 2
laboratories (2) 2
mortality (2) 2
myocardial infarction (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CLINICAL EPIDEMIOLOGY, ISSN 1179-1349, 2014, Volume 6, Issue default, pp. 213 - 220
In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care... 
mortality | epidemiology | atrial fibrillation | risk factors | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | stroke | Complications and side effects | Research | Comorbidity | Atrial fibrillation | Risk factors | Public health | Heart failure | Cardiac arrhythmia | Anticoagulants | Stroke | Mortality | Health care policy | Males | Epidemiology | Studies | Womens health | Older people | Population | Trends
Journal Article
Journal Article
Journal Article
Clinica Chimica Acta, ISSN 0009-8981, 09/2014, Volume 436, pp. 276 - 282
Pre-mRNA splicing defects may have an important impact on clinical phenotype in several diseases, but often their pathogenic role is difficult to demonstrate.... 
Splicing defects | Minigene | In vitro studies | In silico tools | RNA analysis | Expression vectors | DEFECTS | VARIANTS | GENE | DISEASE | MEDICAL LABORATORY TECHNOLOGY | Young Adult | Clinical Laboratory Techniques - methods | Base Sequence | Computer Simulation | Humans | Middle Aged | RNA Splicing - genetics | Lamin Type A - genetics | Exons - genetics | Male | Mutation | Laboratories | Analysis | Methods
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2018, Volume 39, Issue suppl_1
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2018, Volume 39, Issue suppl_1
Journal Article
Revista Uruguaya de Cardiología, ISSN 1688-0420, 12/2015, Volume 30, Issue 3, pp. 347 - 356
En los últimos 20 años la fibrilación auricular (FA) se ha transformado en uno de los problemas de salud pública más importantes. Su prevalencia (2%) duplica... 
SURGERY | MEDICINE, GENERAL & INTERNAL | CARDIAC & CARDIOVASCULAR SYSTEMS
Journal Article
EP Europace, ISSN 1099-5129, 03/2018, Volume 20, Issue suppl_1, pp. i176 - i177
Journal Article
EP Europace, ISSN 1099-5129, 03/2018, Volume 20, Issue suppl_1, pp. i84 - i84
Journal Article
Journal of Cardiovascular Medicine, ISSN 1558-2027, 04/2018, Volume 19, Issue 4, pp. 161 - 169
Journal Article
Journal of Cardiovascular Medicine, ISSN 1558-2027, 04/2018, Volume 19, Issue 4, pp. 170 - 180
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2019, Volume 40, Issue Supplement_1
Abstract Background Heart failure hospitalizations (HFHs) likely represent the main health care expenditure also in implantable cardiac defibrillators (ICDs)... 
Journal Article
Journal of Cardiovascular Medicine, ISSN 1558-2027, 08/2019, Volume 20, Issue 8, pp. 531 - 541
AIMSThe aim of this survey was to assess the management and organization of cardiac implantable electronic device (CIED) replacement in Italy. METHODSA... 
Italian Association of Arrhythmology and Cardiac Pacing survey | SURGERY | INFECTIONS | CARDIAC & CARDIOVASCULAR SYSTEMS | pacemaker | RISK-FACTORS | ORAL ANTICOAGULANT | cardiac resynchronization therapy | PREVENTION | implantable cardioverter defibrillator | THERAPY | ESC GUIDELINES | COMPLICATIONS | CARDIOVERTER-DEFIBRILLATOR REPLACEMENT | replacement | cardiac implantable electronic device | Practice Patterns, Physicians' - economics | Defibrillators, Implantable - economics | Cardiac Pacing, Artificial - trends | Anticoagulants - administration & dosage | Device Removal - adverse effects | Humans | Patient Admission | Prosthesis Failure | Electric Countershock - economics | Time Factors | Device Removal - trends | Cardiac Pacing, Artificial - economics | Pacemaker, Artificial - trends | Length of Stay | Device Removal - economics | Drug Administration Schedule | Treatment Outcome | Electric Countershock - trends | Defibrillators, Implantable - trends | Practice Patterns, Physicians' - trends | Health Care Costs | Pacemaker, Artificial - economics | Electric Countershock - instrumentation | Ambulatory Surgical Procedures | Antibiotic Prophylaxis - trends | Italy | Health Care Surveys | Care and treatment | Usage | Anticoagulants (Medicine) | Dosage and administration | Arrhythmia | Cardiovascular instruments, Implanted
Journal Article
by Mendes-Ferreira, P and Maia-Rocha, C and Adao, R and Lourenco, A. P and Moura, C and Pinho, S and Areias, J. C and De Keulenaer, G. W and Leite-Moreira, A. F and Bras-Silva, C and Holzhauser, L and Lindner, D and Jenke, A and Schultheiss, H.- P and Westermann, D and Skurk, C and Misaka, T and Suzuki, S and Miyata, M and Kobayashi, A and Saitoh, S and Takeishi, Y and Czolbe, M and Pekarek, V and Williams, T and Panther, F and Strassen, J and Ritter, O and Voss, S and Nef, H. M and Szardien, S and Troidl, C and Kojonazarov, B and Visser, D and Hoffmann, J and Willmer, M and Hamm, C. W and Moellmann, H and Ljubojevic, S and Sedej, S and Sacherer, M and Leitinger, G and Kockskaemper, J and Pieske, B and Vorobyeva, N. M and Dobrovolsky, A. B and Titaeva, E. V and Kirienko, A. I and Panchenko, E. P and Nakamura, R and Matsue, Y and Mizukami, A and Ohno, M and Suzuki, M and Matsumura, A and Hashimoto, Y and Rosiak, M and Postula, M and Kaplon-Cieslicka, A and Trzepla, E and Czlonkowski, A and Filipiak, K. J and Opolski, G and Kosior, D. A and Andersson, T and Nagy, P and Niazi, M and Nylander, S and Wallentin, L and Mendell, J and Johnson, L and Ridout, G and He, L and Chen, S and Petrkova, M and Schneiderova, P and Kriegova, E and Kolar, Z and Taborsky, M and Petrek, M and Khuseyinova, N and Schnabel, R and Zeller, T and Gori, T and Schulz, A and Espinola-Klein, C and Lackner, K. J and Blankenberg, S and Muenzel, T. F and Wild, P. S and Amabile, N and Cheng, S and Larson, M. G and Ghorbani, A and Mc Cabe, E and Griffin, G and Cohen, K. S and Tedgui, A and Boulanger, C. M and Wang, T. J and ... and on behalf of BBC ONE investigators and on behalf of WHICH? Trial Investigators and on behalf of EPES Acute Cardiac Care group and on behalf of Interventional Genetic Study Group in Cardiovascular Disease's and on behalf of HPS2-THRIVE Collaborative Group and on behalf of Advantageous Predictors of Acute Coronary Syndrome Evaluation (APACE) and on behalf of The Milan and New-Tokyo Registry and on behalf of SAFETY Investigators and on behalf of Advance CRT Investigators and on behalf of the ARVA Investigators and on behalf of TIMI Study Group and on behalf of REFINE ICD Investigators and on behalf of RO-AHFS Study Investigators and on behalf of The PASCAL Investigators and on behalf of the KorHF investigators and on behalf of TECAM and on behalf of The INSIGHT (R)XT investigators and on behalf of ATA-AF investigators and on behalf of The ODIN Participants and on behalf of CREDO-Kyoto Registry Cohort-2 Investigators and on behalf of AHEAD investigators and on behalf of the RESET investigators and on behalf of ABSORB Cohort B and on behalf of RE-LY Trial Investigators and on behalf of the CORONA Study Group and on behalf of PROTECTOME and on behalf of CoLaus Study and on behalf of OFRECE Study and on behalf of BBK Registry and on behalf of FAST-MI 2010 and on behalf of ATOLL investigators and on behalf of HARVEST study group and on behalf of Royal Brompton Hospital NIHR Cardiovascular Biomedical Research Unit and on behalf of the PROSPER study group and on behalf of MAGGIC study group and on behalf of the DANPACE Investigators and on behalf of German Conn's Registry and on behalf of NANOPLASTY group and on behalf of j-Cypher Registry and on behalf of NIL-CHF Study Investigators and on behalf of the FAST-MI 2010 investigators and on behalf of Competence Network Heart Failure and on behalf of Gothia Cardiovascular and on behalf of OPTIMISE CRT Investigators and on behalf of EVEREST trial investigators and on behalf of The Tohoku Acute Heart Failure Registry and on behalf of investigators of the national registry of ACS, Portuguese Society of Cardiology and on behalf of BIOSOLVE-I Investigators and on behalf of Department of Cardiology, Second Hospital of Tianjin Medical University and on behalf of THALES Registry Investigators and on behalf of STICH Investigators and on behalf of Young @ Heart Investigators and on behalf of PROCARDIS Consortium and on behalf of PEGASO and on behalf of The SWEDEHEART group and on behalf of BWGIC (Belgian Working Group of Invasive Cardiology and on behalf of Med in NRW and For The Topp Registry Investigators and on behalf of PRISON and on behalf of ARISTOTLE investigators and on behalf of the RACE II investigators and on behalf of Euro Heart Survey PCI registry investigators and on behalf of the SPICE investigators and on behalf of The ISAR REACT 4 Investigators and on behalf of Yokohama Medical Center Clinical Research group and on behalf of DiaRegis-Study-Group and on behalf of The RHYTHM-AF Study Scientific Committee and on behalf of the Korea Acute Myocardial Infarction Registry and on behalf of AMIS Plus Investigators and on behalf of SYNTAX Investigators and on behalf of Advantage Predictors of Acute Coronary Syndrome Evaluation and on behalf of CREATE investigator group and on behalf of Follow Your Heart Project and on behalf of SYNTAX Trial Investigators and on behalf of WELCOME Study Investigators and on behalf of Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK) investigators and on behalf of investigators of the national registry of ACS, Portugese Society of Cardiology and on behalf of EVITA-HF (Evidence Based Treatment - Heart Failure) and on behalf of ESTROFA and on behalf of Second Department of Internal Medicine and on behalf of Korea Acute Myocardial Infarction Registry and on behalf of PRAGUE-2 and on behalf of German Diabetes and Dialysis Study Investigators and on behalf of Hull LifeLab and on behalf of on behalf of the DYDA Investigators and on behalf of OFICA study group and on behalf of BASKET-PROVE and on behalf of the Triple-Site versus Standard Resynchronization Therapy Study (TRUST CRT) Investigators and on behalf of Scripps Translational Science Institute and on behalf of OMEGA study group and on behalf of PL-ACS Invastigators and on behalf of German Aortic Valve Therapy Registry and on behalf of TO BELIEVERS and on behalf of PREDICTION Study Group and on behalf of The REACH registry investigators and on behalf of PL-ACS Investigators and on behalf of KNHI and on behalf of Emerging Concepts in Cardiovascular Medicine and on behalf of CHART-2 Investigators and on behalf of the Fushimi AF Registry investigators and on behalf of Brasilian Heart Study Group and on behalf of Taiwan acute coronary syndrome full spetrum registry study group
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue suppl 1, pp. 339 - 653
Journal Article
Journal Article